EMPAGLIFLOZIN (SGLT2 INHIBITOR) IN TYPE 2 DIABETES MELLITUS
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 38
Abstract
BACKGROUND To study the analysis of metabolic parameters in patients with type 2 diabetes mellitus on empagliflozin, which is a SGLT2 inhibitor. MATERIALS AND METHODS This study was a prospective study of 120 patients with uncontrolled type 2 diabetes mellitus who were admitted as outpatients in JLNMCH Hospital, Bhagalpur. This study was conducted from February 2017 to April 2017. Informed consent was taken from each patient who participated in the study and the study protocol was approved by the institutions ethics and review board. Inclusion Criteria- Patients with type 2 diabetes mellitus and HbA1c >8% meeting any one of the criteria- Patients who were on dual therapy (metformin + sulfonylurea/DPP4 inhibitor); patients who were on triple therapy (metformin + sulfonylurea + DPP4 inhibitor); patients who were on insulin and triple oral therapy (metformin + sulfonylurea + DPP4 inhibitor). Exclusion Criteria- Patients who had history of genital mycotic infections, recurrent urinary tract infections, pyelonephritis, acute illness, type 1 diabetes, pregnant or lactating women, those patients who were with an eGFR below 45. RESULTS The mean age, duration of diabetes, weight and HbA1c in the study population was 54.36 ± 0.88 years, 14.2 ± 3.6 years, 76.25 ± 2.11 kgs and 9.66 ± 0.22%, respectively. The changes in weight and HbA1c were statistically significant across all groups. In 5% of the patients, genital pruritus was reported. Mycotic genital infection was seen in none of the patients on examination. All the four groups chose to discontinue the use of empagliflozin as a result of pruritus at follow up. The baseline daily insulin dose was 42 ± 25 units, and at 4 months, it was reduced to 34 ± 20 units. At follow up, the reduction in insulin level was 19.1% when compared to baseline. CONCLUSION This study showed that there was an improvement in glycaemic control and body weight with minimal side effects when SGLT2 inhibitor was added at any stage of disease with any of the pre-existing therapeutic agents for patients who had uncontrolled T2DM.
Authors and Affiliations
Mohammed Umar Farooque, Bharat Bhushan
Keywords
Related Articles
- EP ID EP219150
- DOI 10.18410/jebmh/2017/456
- Views 69
- Downloads 0
COMPARISON OF SEDATIVE AND HAEMODYNAMIC EFFECTS OF INTRAVENOUS DEXMEDETOMIDINE AND MIDAZOLAM COMBINATION AND INTRAVENOUS DEXMEDETOMIDINE IN CHILDREN UNDERGOING MAGNETIC RESONANCE IMAGING
BACKGROUND Sedation is a necessity for MR procedures conducted in children for adequate alleviation of anxiety, pain relief while securing IV access, and in order to avoid movements during the procedure. Dexmedetomidine,...
UNILATERAL MEMBRANOUS ATRESIA WITH OSSICULAR MALROTATION AND CONGENITAL CHOLESTEATOMA
INTRODUCTION Congenital cholesteatoma is a rare entity, arising from aberrant epithelial remnants left at the time of closure of the neural groove between the third and fifth week of fetal life with incidence ranging fro...
ADVERSE EFFECTS OF ANTITUBERCULOSIS DRUGS IN PATIENTS UNDER DOTS CATEGORY-1
BACKGROUND This study intends to analyse the clinical findings, haematological and biochemical parameters of adverse drug effects of antituberculosis drugs in patients started on DOTS category-1. Since, ATT is an effecti...
TIMING OF REPLANNING IN HEAD AND NECK CANCERS ON RADIATION BY IMRT AND ITS SIGNIFICANCE IN TUMOUR VOLUME AND CRITICAL STRUCTURE VOLUME AND DOSE
BACKGROUND Radiation to head and neck cancers by Intensity Modulated Radiotherapy (IMRT) is associated with high-dose conformality to target volume, which results in reduced dose to the critical normal tissues. Average d...
IMPACT OF ALCOHOL ON HUMAN VITAL SEMINAL PARAMETER WHICH INFLUENCE FERTILITY
Alcohol has wide impact (affect) on male reproductive function like impotence, loss of sexual interest, gynecomastia and on male infertility. Alcohol can adversely affect the leydig cells which secretes the male hormone...